臨床試験を検索:ドルテグラビル (Tivicay®) - 第 1 相
合計1257件
-
Heinrich-Heine University, Duesseldorf終了しました
-
Mylan Pharmaceuticals Private Limited完了
-
Washington University School of MedicineKaryopharm Therapeutics Inc完了
-
The Baruch Padeh Medical Center, Poriyaわからない
-
University of Kansas Medical CenterNational Institutes of Health (NIH); American Diabetes Association; GI Stimulation, Inc.完了
-
Michael HoelscherRadboud University Medical Center; German Federal Ministry of Education and Research; European...完了
-
Yonsei University完了
-
University of FloridaState of Florida Consortium for Medical Marijuana Clinical Outcomes Research完了
-
Fundación HuéspedViiV Healthcare完了
-
The New York Eye Surgery CenterOcular Therapeutix, Inc.終了しました
-
The Cleveland ClinicOcular Therapeutix, Inc.招待による登録
-
Jason J. Luke, MDBristol-Myers Squibb募集
-
Medtronic - MITGInstitute for Skin Research, Israel完了
-
Haisco Pharmaceutical Group Co., Ltd.The Fourth Hospital of Hebei Medical University募集
-
Castagna AntonellaBristol-Myers Squibb; ViiV Healthcare完了
-
University of North Carolina, Chapel HillNational Institute of Allergy and Infectious Diseases (NIAID)完了
-
Teva Branded Pharmaceutical Products R&D, Inc.完了
-
Merck KGaA, Darmstadt, GermanyMerck B.V., Netherlands; Merck A.E., Greece; Merck OY, Finland; Merck A.B., Sweden; Merck, S.A., Portugal完了
-
UCB Pharma SA終了しました
-
Boehringer Ingelheim完了
-
Instituto Valenciano de Infertilidad, IVI VALENCIAAnecova SA終了しました
-
M.D. Anderson Cancer CenterBayer; Astex Pharmaceuticals, Inc.終了しました
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; National Cancer Institute (NCI); Aduro Biotech, Inc.完了
-
Pharmtechnology LLCAltasciences Company, Inc.完了
-
Ariad Pharmaceuticals完了慢性骨髄性白血病 (CML) | フィラデルフィア染色体陽性の急性リンパ芽球性白血病 (Ph+ ALL)日本
-
University of Sao Paulo General HospitalHospital Santa Marcelina募集炎症 | COVID19 | コロナウイルスブラジル
-
National Institute of Allergy and Infectious Diseases...完了
-
Glenmark Pharmaceuticals Ltd. India完了